A Dubai laboratory buying research peptides runs the same sequence every time: define the exact SKU, pull the documentation, raise the requisition, get it approved, pay in AED, receive against the order, and file the record. The sequence is not complicated. It breaks in predictable places, almost always because a step was done from memory instead of from a document. This is the workflow written out end to end, with the point of failure named at each stage.
Step one: fix the SKU, not the compound name
Write the catalogue SKU and the vial format on the requisition, not a generic compound name. "GHK-Cu" is a compound; a 50 mg vial with a catalogue identifier is a purchasable item. Accounts payable will reject a 100 mg receipt against a 50 mg order even when the peptide identity is identical, and that rejection lands on whoever raised the request. Browse the listings as they will appear on the invoice via buy research peptides in Dubai and the Dubai supplier overview.
Step two: pull documentation before the requisition, not after
Get the lot record or its current equivalent in front of you before anything enters the approval system. Approvers ask for evidence; supplying it in the same submission removes a round trip that typically costs days. Check the COA library for the item, and where a specific lot is not yet published, use